2gmv
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:2gmv. | + | {{Seed}} |
+ | [[Image:2gmv.png|left|200px]] | ||
<!-- | <!-- | ||
Line 9: | Line 10: | ||
{{STRUCTURE_2gmv| PDB=2gmv | SCENE= }} | {{STRUCTURE_2gmv| PDB=2gmv | SCENE= }} | ||
- | + | ===PEPCK complex with a GTP-competitive inhibitor=== | |
- | + | <!-- | |
- | + | The line below this paragraph, {{ABSTRACT_PUBMED_17532214}}, adds the Publication Abstract to the page | |
+ | (as it appears on PubMed at http://www.pubmed.gov), where 17532214 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_17532214}} | ||
==Disease== | ==Disease== | ||
Line 23: | Line 27: | ||
==Reference== | ==Reference== | ||
C-8 Modifications of 3-alkyl-1,8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase., Pietranico SL, Foley LH, Huby N, Yun W, Dunten P, Vermeulen J, Wang P, Toth K, Ramsey G, Gubler ML, Wertheimer SJ, Bioorg Med Chem Lett. 2007 Jul 15;17(14):3835-9. Epub 2007 May 22. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17532214 17532214] | C-8 Modifications of 3-alkyl-1,8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase., Pietranico SL, Foley LH, Huby N, Yun W, Dunten P, Vermeulen J, Wang P, Toth K, Ramsey G, Gubler ML, Wertheimer SJ, Bioorg Med Chem Lett. 2007 Jul 15;17(14):3835-9. Epub 2007 May 22. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17532214 17532214] | ||
+ | |||
+ | X-ray structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1,8-dibenzylxanthines., Foley LH, Wang P, Dunten P, Ramsey G, Gubler ML, Wertheimer SJ, Bioorg Med Chem Lett. 2003 Nov 3;13(21):3871-4. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/14552798 14552798] | ||
+ | |||
+ | Crystal structure of human cytosolic phosphoenolpyruvate carboxykinase reveals a new GTP-binding site., Dunten P, Belunis C, Crowther R, Hollfelder K, Kammlott U, Levin W, Michel H, Ramsey GB, Swain A, Weber D, Wertheimer SJ, J Mol Biol. 2002 Feb 15;316(2):257-64. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11851336 11851336] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
Line 29: | Line 37: | ||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Xanthine]] | [[Category: Xanthine]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun | + | |
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 15:11:36 2008'' |
Revision as of 12:11, 27 July 2008
Contents |
PEPCK complex with a GTP-competitive inhibitor
Template:ABSTRACT PUBMED 17532214
Disease
Known disease associated with this structure: Hypoglycemia due to PCK1 deficiency (1) OMIM:[261680]
About this Structure
2GMV is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
C-8 Modifications of 3-alkyl-1,8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase., Pietranico SL, Foley LH, Huby N, Yun W, Dunten P, Vermeulen J, Wang P, Toth K, Ramsey G, Gubler ML, Wertheimer SJ, Bioorg Med Chem Lett. 2007 Jul 15;17(14):3835-9. Epub 2007 May 22. PMID:17532214
X-ray structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1,8-dibenzylxanthines., Foley LH, Wang P, Dunten P, Ramsey G, Gubler ML, Wertheimer SJ, Bioorg Med Chem Lett. 2003 Nov 3;13(21):3871-4. PMID:14552798
Crystal structure of human cytosolic phosphoenolpyruvate carboxykinase reveals a new GTP-binding site., Dunten P, Belunis C, Crowther R, Hollfelder K, Kammlott U, Levin W, Michel H, Ramsey GB, Swain A, Weber D, Wertheimer SJ, J Mol Biol. 2002 Feb 15;316(2):257-64. PMID:11851336
Page seeded by OCA on Sun Jul 27 15:11:36 2008